PELVIC DEFORMITY

This adverse event was reported 129 times

PELVIC DEFORMITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRIMIPRAMINE MALEATE 1 0.0025
1 ROLAPITANT 1 0.0019
2 HYDROXOCOBALAMIN 7 0.0017
3 DEXTROMETHORPHAN POLISTIREX 1 0.0013
4 MOGAMULIZUMAB-KPKC 1 0.0007
5 ESTRADIOL/NORETHINDRONE ACETATE 1 0.0005
6 ONASEMNOGENE ABEPARVOVEC-XIOI 1 0.0004
7 METHYLCELLULOSE 1 0.0004
8 DEFLAZACORT 1 0.0004
9 VALPROATE SODIUM 7 0.0003
See all drugs enriched for association with PELVIC DEFORMITY

PELVIC DEFORMITY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Chemokine Receptor Type 4 Interaction [EPC] 1 0.0007
1 Survival of Motor Neuron 2 Splicing Modifier [EPC] 1 0.0002
2 Bismuth [EPC] 1 0.0002
3 Orexin Receptor Antagonist [EPC] 3 0.0002
4 Antidote [EPC] 9 0.0001
5 Vitamin D2 Analog [EPC] 1 0.0001
6 Provitamin D2 Compound [EPC] 4 0.0001
7 Vitamin K [EPC] 1 0.0001
8 Muscle Relaxant [EPC] 4 0.0001
9 Antisense Oligonucleotide [EPC] 1 0.0001
See all drug classes enriched for association with PELVIC DEFORMITY